Synthetic Biologics Announces Planned Acquisition Of VCN Biosciences; Total Upfront Consideration Of $4.7M In Cash Plus Assumption Of $2.4M VCN Liabilities

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.